Psoriasis Completed Phase 1 Trials for Water (DB09145)

Also known as: PSORIASIS / Psoriasis unspecified / Psoriasis, unspecified

IndicationStatusPhase
DBCOND0013339 (Psoriasis)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01276847A Study to Assess the Effect of Ustekinumab (Stelara®) and Etanercept (Enbrel®) in Participants With Moderate to Severe Psoriasis (MK-0000-206)Treatment